全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

三阴性乳腺癌miRNA主调控因子的分析鉴定
Analysis and Identification of miRNA Master Regulators in Triple Negative Breast Cancer (TNBC)

DOI: 10.12677/HJBM.2021.112012, PP. 87-95

Keywords: 三阴性乳腺癌,miRNA,生物信息学
Triple Negative Breast Cancer (TNBC)
, miRNA, Bioinformatics

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的:通过生物信息学方法分析与三阴性乳腺癌发生发展有关的关键miRNA。方法:从GEO数据库中找到三阴性乳腺癌miRNA数据集GSE121657,利用GEO2R鉴定差异表达的miRNA,通过starBase数据库预测出差异表达的miRNA所对应的靶基因,并对靶基因进行GO基因功能富集分析以及KEGG信号通路分析,最后建立编码蛋白互作网络并且从中筛查出关键的miRNA。结果:筛选出61个差异表达的miRNA,获得与之相对应的165个靶基因,这些靶基因主要涉及到细胞的定位、细胞周期、细胞分裂、细胞凋亡等生物学过程,参与PI3K-Akt、多巴胺能突触、Hippo、MAPK等信号通路的调控,找到关键性的调控因子hsa-miR-141-3p。结论:生物信息学分析提示hsa-miR-141-3p可能是三阴性乳腺癌重要的调控因子。
Objective: The key miRNA in triple negative breast cancer (TNBC) was analyzed by bioinformatics analysis. Method: The Gene Expression Omnibus (GEO) dataset (GSE121657) was chosen and ex-plored to identify differentially expressed miRNAs using GEO2R, and the target genes matching for the miRNAs were predicted by starBase. Enrichment analysis of Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) was performed by the DAVID online tool. The networks between miRNAs and hub genes were constructed by Cytoscape software. Results: 61 differentially expressed microRNAs were screened and 165 corresponding target genes were obtained. These target genes mainly involved in biological processes such as cell location, cell cycle, cell division, cell apoptosis, etc., and mainly participated in PI3K-Akt, dopaminergic synapse, Hippo, and MAPK sig-naling pathways. The key regulatory factors hsa-mir-141-3p have been screened by the signal pathway, insulin pathway and MAPK pathway. Conclusion: Bioinformatics analysis suggested miR-NA hsa-mir-141-3p may is a good classifier of TNBC and might play key roles in the progression of TNBC.

References

[1]  李贺, 郑荣寿, 张思维, 等. 2014年中国女性乳腺癌发病与死亡分析[J]. 中华肿瘤杂志, 2018, 40(3): 166-171.
[2]  Gelmon, K., Dent, R., Mackey, J.R., et al. (2012) Targeting Triple-Negative Breast Cancer: Optimising Therapeutic Outcomes. Annals of Oncology, 23, 2223-2234.
https://doi.org/10.1093/annonc/mds067
[3]  黎辉, 韩明其, 陈明光. 三阴性乳腺癌的病理特征及临床预后探讨[J]. 中外医疗, 2020, 39(2): 29-31.
[4]  Liedtke, C., Rody, A. and Gluz, O. (2015) The Prognostic Impact of Age in Different Molecular Subtypes of Breast Cancer. Breast Cancer Research and Treatment, 152, 667-673.
https://doi.org/10.1007/s10549-015-3491-3
[5]  Cinkaya, A., Akin, M. and Sengul, A. (2016) Evaluation of Treatment Outcomes of Triple-Negative Breast Cancer. Journal of Cancer Research and Therapeutics, 12, 150-154.
https://doi.org/10.4103/0973-1482.154000
[6]  曹晓珊, 丛斌斌. 精准医学时代三阴性乳腺癌治疗的研究进展[J]. 中国癌症杂志, 2019, 29(12): 971-976.
[7]  修萌, 张频. 早期三阴性乳腺癌治疗模式及新辅助治疗研究进展[J/OL]. 肿瘤防治研究, 2020, 47(2): 53-58.
[8]  李甜, 周钱梅, 张卫红. PI3K/Akt/mTOR信号通路在三阴性乳腺癌治疗中的研究进展[J]. 中国肿瘤, 2018, 27(1): 40-45.
[9]  Yutaro, G., Aye, T., Hui, O.C.C., et al. (2020) Characteristics, Behaviour and Role of Biomarkers in Metastatic Triple-Negative Breast Cancer. Journal of Clinical Pathology, 73.
https://doi.org/10.1136/jclinpath-2019-206078
[10]  郑健, 张雪鹏. 微小RNA在三阴性乳腺癌中的研究进展[J]. 华北理工大学学报(医学版), 2016, 18(6): 499-504.
[11]  冷红. 基于生物信息学筛选三阴性乳腺癌差异表达基因[D]: [硕士学位论文]. 泸州: 西南医科大学, 2019.
[12]  Wong, C.K., Gromisch, C., Ozturk, S., et al. (2019) MicroRNA-4417 Is a Tumor Suppressor and Prognostic Biomarker for Triple-Negative Breast Cancer. Cancer Biology & Therapy, 20, 1113-1120.
https://doi.org/10.1080/15384047.2019.1595285
[13]  Zhou, K.R., Liu, S., Cai, L., Bin, L., et al. (n.d.) ENCORI: The Encyclopedia of RNA Interactomes.
[14]  Li, J.H., et al. (2014) starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and Protein-RNA Interaction Networks from Large-Scale CLIP-Seq Data. Nucleic Acids Research, 42, D92-D97.
https://doi.org/10.1093/nar/gkt1248
[15]  Lewis, B.P., Burge, C.B. and Bartel, D.P. (2005) Conserved Seed Pairing, Often Flanked by Adenosines, Indicates That Thousands of Human Genes Are microRNA Targets. Cell, 120, 15.
https://doi.org/10.1016/j.cell.2004.12.035
[16]  田亚丽, 古丽海夏?哈勒玛合拜, 张燕, 张之. 外泌体微小RNA与胰岛素抵抗的研究现状[J]. 中国临床药理学杂志, 2020, 36(8): 1016-1019.
[17]  武强, 赵全年, 宋卫东. PI3K/Akt/mTOR信号传导通路在肿瘤的研究进展[J]. 疾病监测与控制, 2013, 7(6): 346-347.
[18]  Massihnia, D., Perez, A., Bazan, V., et al. (2016) A Headlight on Liquid Biopsies: A Challenging Tool for Breast Cancer Management. Tumor Biology, 37, 4263-4273.
https://doi.org/10.1007/s13277-016-4856-x
[19]  Guan, G.Y., Niu, X., Qiao, X., et al. (2020) Upregulation of Neural Cell Adhesion Molecule 1 (NCAM1) by hsa-miR-141-3p Suppresses Ameloblastoma Cell Migration. Medical Science Monitor, 26, e923491.
https://doi.org/10.12659/MSM.923491
[20]  Huang, S., Wa, Q., Pan, J., et al. (2017) Downregulation of miR-141-3p Promotes Bone Metastasis via Activating NF-kappaB Signaling in Prostate Cancer. Journal of Experimental & Clinical Cancer Research, 36, 173.
https://doi.org/10.1186/s13046-017-0645-7
[21]  Liang, Z., Li, X., Liu, S., et al. (2019) MiR-141-3p Inhibits Cell Proliferation, Migration and Invasion by Targeting TRAF5 in Colorectal Cancer. Biochemical and Biophysical Research Communications, 514, 699-705.
https://doi.org/10.1016/j.bbrc.2019.05.002
[22]  Li, J.H., Zhang, Z., Du, M.Z., et al. (2018) microRNA-141-3p Fosters the Growth, Invasion, and Tumorigenesis of Cervical Cancer Cells by Targeting FOXA2. Archives of Biochemistry and Biophysics, 657, 23-30.
https://doi.org/10.1016/j.abb.2018.09.008

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133